Startseite UB

Intracavitary doxorubicin hydrochloride therapy for carcinoma in situ of the bladder

Jakse, G. and Hofstädter, Ferdinand and Marberger, H. (1981) Intracavitary doxorubicin hydrochloride therapy for carcinoma in situ of the bladder. The Journal of Urology = J. Urol. 125 (2), pp. 185-190.

Full text not available from this repository.

at PubMed


Abstract

We treated 15 patients with carcinoma in situ of the bladder by intravesical instillation of doxorubicin hydrochloride. Different dose and interval schedules, that is 40 mg. biweekly and 80 mg. monthly, each resulted in a 66 per cent tumor remission rate. In no instance were undue systemic effects noted; the local side effects were negligible. Cold cup random biopsies were obtained before and ...

plus


Export bibliographical data



Item Type:Article
Date:1981
Institutions:Medicine > Lehrstuhl für Pathologie
Identification Number:
ValueType
7206051PubMed ID
Classification:
NotationType
Administration, TopicalMESH
AdultMESH
AgedMESH
Carcinoma in Situ/drug therapyMESH
Doxorubicin/therapeutic useMESH
FemaleMESH
HumansMESH
MaleMESH
Middle AgedMESH
Urinary Bladder Neoplasms/drug therapyMESH
Subjects:600 Technology > 610 Medical sciences Medicine
Status:Published
Refereed:Unknown
Created at the University of Regensburg:Unknown
Owner: Gertraud Kellers
Deposited On:14 May 2010 11:30
Last Modified:14 May 2010 11:30
Item ID:14782
Owner Only: item control page
  1. University

University Library

Publication Server

Contact person
Gernot Deinzer

Telefon 0941 943-2759
Contact